Cite

1. Kumar S, Singh R, Malik S, Manne U, Mishra M. Prostate cancer health disparities: An immuno-biological perspective. Cancer Lett. 2018;414:153-65.10.1016/j.canlet.2017.11.011574361929154974 Search in Google Scholar

2. Saraon P, Drabovich AP, Jarvi KA, Diamandis EP. Mechanisms of androgen-independent prostate cancer. EJIFCC. 2014;25(1):42-54. Search in Google Scholar

3. Smith ZL, Eggener SE, Murphy AB. African-American prostate cancer disparities. Curr Urol Rep. 2017;18(10):81.10.1007/s11934-017-0724-528808871 Search in Google Scholar

4. Evans S, Metcalfe C, Ibrahim F, Persad R, Ben-Shlomo Y. Investigating black-white differences in prostate cancer prognosis: A systematic review and meta-analysis. Int J Cancer. 2008;123(2):430-5.10.1002/ijc.2350018452170 Search in Google Scholar

5. Peprah E, Xu H, Tekola-Ayele F, Royal CD. Genome-wide association studies in Africans and African Americans: Expanding the framework of the genomics of human traits and disease. Public Health Genom. 2015;18(1):40-51.10.1159/000367962441847725427668 Search in Google Scholar

6. Ali-Seyed M, Jantan I, Vijayaraghavan K, Bukhari SN. Betulinic acid: Recent advances in chemical modifications, effective delivery, and molecular mechanisms of a promising anticancer therapy. Chem Biol Drug Des. 2016;87(4):517-36.10.1111/cbdd.1268226535952 Search in Google Scholar

7. Hordyjewska A, Ostapiuk A, Horecka A, Kurzepa J. Betulin and betulinic acid: triterpenoids derivatives with a powerful biological potential. Phytochem Rev. 2019;18(3):929-51.10.1007/s11101-019-09623-1 Search in Google Scholar

8. Jäger S, Winkler K, Pfüller U, Scheffler A. Solubility studies of oleanolic acid and betulinic acid in aqueous solutions and plant extracts of Viscum album L. Planta Med. 2007;73(02):157-62.10.1055/s-2007-96710617415876 Search in Google Scholar

9. Zhao H, Jones CL, Cowins JV. Lipase dissolution and stabilization in ether-functionalized ionic liquids. Green Chem. 2009;11(8):1128-38.10.1039/b905388c Search in Google Scholar

10. Yogeeswari P, Sriram D. Betulinic acid and its derivatives: a review on their biological properties. Curr Med Chem. 2005;12(6):657-66.10.2174/092986705320221415790304 Search in Google Scholar

11. Baglin I, Mitaine-Offer A-C, Nour M, Tan K, Cave C, Lacaille-Dubois M-A. A review of natural and modified betulinic, ursolic and echinocystic acid derivatives as potential antitumor and anti-HIV agents. Mini Rev Med Chem. 2003;3(6):525-39.10.2174/138955703348791712871156 Search in Google Scholar

12. Suresh C, Zhao H, Gumbs A, Chetty CS, Bose HS. New ionic derivatives of betulinic acid as highly potent anti-cancer agents. Bioorg Med Chem Lett. 2012;22(4):1734-8.10.1016/j.bmcl.2011.12.102327463722264477 Search in Google Scholar

13. Lee AS. GRP78 induction in cancer: therapeutic and prognostic implications. Cancer Res. 2007;67(8):3496-9.10.1158/0008-5472.CAN-07-032517440054 Search in Google Scholar

14. Kim C, Kim B. Anti-cancer natural products and their bioactive compounds inducing ER stress-mediated apoptosis: A review. Nutrients. 2018;10(8).10.3390/nu10081021611582930081573 Search in Google Scholar

15. Cai Y, Zheng Y, Gu J, Wang S, Wang N, Yang B, et al. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78. Cell Death Dis. 2018;9(6):636.10.1038/s41419-018-0669-8597019629802332 Search in Google Scholar

16. Horoszewicz JS, Leong SS, Chu TM, Wajsman ZL, Friedman M, Papsidero L, et al. The LNCaP cell line--a new model for studies on human prostatic carcinoma. Prog Clin Biol Res. 1980;37:115-32. Search in Google Scholar

17. Stone KR, Mickey DD, Wunderli H, Mickey GH, Paulson DF. Isolation of a human prostate carcinoma cell line (DU 145). Int J Cancer. 1978;21(3):274-81.10.1002/ijc.2910210305631930 Search in Google Scholar

18. Alimirah F, Chen J, Basrawala Z, Xin H, Choubey D. DU-145 and PC-3 human prostate cancer cell lines express androgen receptor: implications for the androgen receptor functions and regulation. FEBS Lett. 2006;580(9):2294-300.10.1016/j.febslet.2006.03.04116580667 Search in Google Scholar

19. Kaighn M, Narayan KS, Ohnuki Y, Lechner J, Jones L. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol. 1979;17(1):16-23. Search in Google Scholar

20. Koochekpour S, Maresh GA, Katner A, Parker-Johnson K, Lee TJ, Hebert FE, et al. Establishment and characterization of a primary androgen-responsive African-American prostate cancer cell line, E006AA. Prostate. 2004;60(2):141-52.10.1002/pros.2005315162380 Search in Google Scholar

21. Koochekpour S, Willard SS, Shourideh M, Ali S, Liu C, Azabdaftari G, et al. Establishment and characterization of a highly tumorigenic African American prostate cancer cell line, E006AA-hT. Int J Biol Sci. 2014;10(8):834-45.10.7150/ijbs.9406411519525076860 Search in Google Scholar

22. Theodore S, Sharp S, Zhou J, Turner T, Li H, Miki J, et al. Establishment and characterization of a pair of non-malignant and malignant tumor derived cell lines from an African American prostate cancer patient. Int J Oncol. 2010;37(6):1477-82.10.3892/ijo_00000800 Search in Google Scholar

23. Phillips J, Phillips I, Enya B, Zhao H, Nitta T. Effect of betulinic acid and its ionic derivatives on M-MuLV replication. Biochem Biophys Res Commun. 2018;500(2):365-9.10.1016/j.bbrc.2018.04.080609320429660337 Search in Google Scholar

24. Pozarowska D, Pozarowski P. Benzalkonium chloride (BAK) induces apoptosis or necrosis, but has no major influence on the cell cycle of Jurkat cells. Folia Histochem Cytobiol. 2011;49(2):225-30.10.5603/FHC.2011.003121744321 Search in Google Scholar

25. Choi SM, Roh TH, Lim DS, Kacew S, Kim HS, Lee BM. Risk assessment of benzalkonium chloride in cosmetic products. J Toxicol Environ Health B Crit Rev. 2018;21(1):8-23.10.1080/10937404.2017.140855229211634 Search in Google Scholar

26. Lou H, Li H, Zhang S, Lu H, Chen Q. A review on preparation of betulinic acid and its biological activities. Molecules. 2021;26(18).10.3390/molecules26185583846826334577056 Search in Google Scholar

27. Jiang W, Li X, Dong S, Zhou W. Betulinic acid in the treatment of tumour diseases: Application and research progress. Biomed Pharmacother. 2021;142:111990.10.1016/j.biopha.2021.11199034388528 Search in Google Scholar

28. Shin J, Lee HJ, Jung DB, Jung JH, Lee HJ, Lee EO, et al. Suppression of STAT3 and HIF-1 alpha mediates anti-angiogenic activity of betulinic acid in hypoxic PC-3 prostate cancer cells. PLoS One. 2011;6(6):e21492.10.1371/journal.pone.0021492312334321731766 Search in Google Scholar

29. Chintharlapalli S, Papineni S, Ramaiah SK, Safe S. Betulinic acid inhibits prostate cancer growth through inhibition of specificity protein transcription factors. Cancer Res. 2007;67(6):2816-23.10.1158/0008-5472.CAN-06-373517363604 Search in Google Scholar

30. Shankar E, Zhang A, Franco D, Gupta S. Betulinic acid-mediated apoptosis in human prostate cancer ells involves p53 and nuclear factor-kappa B (NF-kappaB) pathways. Molecules. 2017;22(2).10.3390/molecules22020264583205928208611 Search in Google Scholar

31. Kessler JH, Mullauer FB, de Roo GM, Medema JP. Broad in vitro efficacy of plant-derived betulinic acid against cell lines derived from the most prevalent human cancer types. Cancer Lett. 2007;251(1):132-45.10.1016/j.canlet.2006.11.00317169485 Search in Google Scholar

32. Rabi T, Shukla S, Gupta S. Betulinic acid suppresses constitutive and TNFalpha-induced NF-kappaB activation and induces apoptosis in human prostate carcinoma PC-3 cells. Mol Carcinog. 2008;47(12):964-73.10.1002/mc.20447286472118444250 Search in Google Scholar

33. Reiner T, Parrondo R, de Las Pozas A, Palenzuela D, Perez-Stable C. Betulinic acid selectively increases protein degradation and enhances prostate cancer-specific apoptosis: possible role for inhibition of deubiquitinase activity. PLoS One. 2013;8(2):e56234.10.1371/journal.pone.0056234357042223424652 Search in Google Scholar

34. Badal S, Aiken W, Morrison B, Valentine H, Bryan S, Gachii A, et al. Disparities in prostate cancer incidence and mortality rates: Solvable or not? Prostate. 2020;80(1):3-16.10.1002/pros.23923837824631702061 Search in Google Scholar

35. Hu H, Tian M, Ding C, Yu S. The C/EBP Homologous Protein (CHOP) transcription factor functions in endoplasmic reticulum stress-induced apoptosis and microbial infection. Front Immunol. 2018;9:3083.10.3389/fimmu.2018.03083 Search in Google Scholar

36. Lo WL, Hsu TI, Yang WB, Kao TJ, Wu MH, Huang YN, et al. Betulinic acid-mediated tuning of PERK/CHOP signaling by Sp1 inhibition as a Novel Therapeutic Strategy for Glioblastoma. Cancers (Basel). 2020;12(4).10.3390/cancers12040981 Search in Google Scholar

37. Miyake H, Hara I, Arakawa S, Kamidono S. Stress protein GRP78 prevents apoptosis induced by calcium ionophore, ionomycin, but not by glycosylation inhibitor, tunicamycin, in human prostate cancer cells. J Cell Biochem. 2000;77(3):396-408.10.1002/(SICI)1097-4644(20000601)77:3<396::AID-JCB5>3.0.CO;2-5 Search in Google Scholar

38. Kim SJ, Quan HY, Jeong KJ, Kim DY, Kim G, Jo HK, et al. Beneficial effect of betulinic acid on hyperglycemia via suppression of hepatic glucose production. J Agric Food Chem. 2014;62(2):434-42.10.1021/jf4030739 Search in Google Scholar

39. De Saint Jean M, Brignole F, Bringuier AF, Bauchet A, Feldmann G, Baudouin C. Effects of benzalkonium chloride on growth and survival of Chang conjunctival cells. Invest Ophthalmol Vis Sci. 1999;40(3):619-30. Search in Google Scholar

40. Smukste I, Bhalala O, Persico M, Stockwell BR. Using small molecules to overcome drug resistance induced by a viral oncogene. Cancer Cell. 2006;9(2):133-46.10.1016/j.ccr.2006.01.012 Search in Google Scholar

eISSN:
2300-6676
Idioma:
Inglés
Calendario de la edición:
4 veces al año
Temas de la revista:
Medicine, Clinical Medicine, other, Pharmacology, Toxicology, Pharmacy